LUNSEN GIL J VAN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for LUNSEN GIL J VAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of LUNSEN GIL J VAN. LUNSEN GIL J VAN is in ARRAY BIOPHARMA INC ($ARRY) and Director in ARRAY BIOPHARMA INC ($ARRY) and Director in MACOM Technology Solutions Holdings, Inc. ($MTSI).
Latest Insider Trading Transactions of LUNSEN GIL J VAN
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 11 2021 | MTSI | MACOM Technology S ... | VAN LUNSEN GIL J | Director | Grant | A | 0.00 | 2,903 | 0 | 35,848 | 32.9 K to 35.8 K (+8.81 %) |
Mar 10 2020 | MTSI | MACOM Technology S ... | VAN LUNSEN GIL J | Director | Grant | A | 0.00 | 5,414 | 0 | 32,945 | 27.5 K to 32.9 K (+19.67 %) |
Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Director | Option Exercise | D | 14.55 | 25,000 | 363,750 | 0 | |
Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Director | Option Exercise | D | 10.47 | 25,000 | 261,750 | 0 | |
Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Director | Sell | D | 0.00 | 5,000 | 0 | 0 | 5 K to 0 (-100.00 %) |
Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Director | Sell | D | 48.00 | 24,297 | 1,166,256 | 5,000 | 29.3 K to 5 K (-82.93 %) |
Mar 05 2019 | MTSI | MACOM Technology S ... | VAN LUNSEN GIL J | Director | Grant | A | 0.00 | 6,656 | 0 | 27,531 | 20.9 K to 27.5 K (+31.89 %) |
Oct 29 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Option Exercise | M | 0.00 | 5,000 | 0 | 0 | ||
Oct 29 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | ||
Oct 29 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Option Exercise | A | 14.55 | 25,000 | 363,750 | 25,000 | ||
Oct 29 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Buy | M | 0.00 | 5,000 | 0 | 24,297 | 19.3 K to 24.3 K (+25.91 %) | |
Sep 21 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Option Exercise | M | 5.95 | 18,000 | 107,100 | 0 | ||
Sep 21 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Sell | S | 14.76 | 18,000 | 265,684 | 19,297 | 37.3 K to 19.3 K (-48.26 %) | |
Sep 21 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Buy | M | 5.95 | 18,000 | 107,100 | 37,297 | 19.3 K to 37.3 K (+93.28 %) | |
Aug 17 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Option Exercise | M | 5.60 | 14,500 | 81,200 | 0 | ||
Aug 17 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Option Exercise | M | 5.60 | 14,500 | 81,200 | 0 | ||
Aug 17 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Option Exercise | M | 5.95 | 7,000 | 41,650 | 18,000 | ||
Aug 17 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Option Exercise | M | 5.95 | 7,000 | 41,650 | 18,000 | ||
Aug 17 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Sell | S | 13.92 | 21,500 | 299,280 | 19,297 | 40.8 K to 19.3 K (-52.70 %) | |
Aug 17 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Sell | S | 13.92 | 21,500 | 299,280 | 19,297 | 40.8 K to 19.3 K (-52.70 %) | |
Aug 17 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Buy | M | 5.60 | 14,500 | 81,200 | 40,797 | 26.3 K to 40.8 K (+55.14 %) | |
Aug 17 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Buy | M | 5.60 | 14,500 | 81,200 | 40,797 | 26.3 K to 40.8 K (+55.14 %) | |
Aug 17 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Buy | M | 5.95 | 7,000 | 41,650 | 26,297 | 19.3 K to 26.3 K (+36.28 %) | |
Aug 17 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Buy | M | 5.95 | 7,000 | 41,650 | 26,297 | 19.3 K to 26.3 K (+36.28 %) | |
Jul 19 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Option Exercise | M | 5.13 | 11,000 | 56,430 | 0 | ||
Jul 19 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Option Exercise | M | 5.60 | 10,500 | 58,800 | 14,500 | ||
Jul 19 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Sell | S | 16.56 | 21,500 | 356,040 | 19,297 | 40.8 K to 19.3 K (-52.70 %) | |
Jul 19 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Buy | M | 5.13 | 11,000 | 56,430 | 40,797 | 29.8 K to 40.8 K (+36.92 %) | |
Jul 19 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Buy | M | 5.60 | 10,500 | 58,800 | 29,797 | 19.3 K to 29.8 K (+54.41 %) | |
Jun 21 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Option Exercise | M | 4.36 | 7,500 | 32,700 | 0 | ||
Jun 21 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Option Exercise | M | 5.13 | 14,000 | 71,820 | 11,000 | ||
Jun 21 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Sell | S | 19.08 | 21,500 | 410,220 | 19,297 | 40.8 K to 19.3 K (-52.70 %) | |
Jun 21 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Buy | M | 5.13 | 14,000 | 71,820 | 40,797 | 26.8 K to 40.8 K (+52.24 %) | |
Jun 21 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Buy | M | 4.36 | 7,500 | 32,700 | 26,797 | 19.3 K to 26.8 K (+38.87 %) | |
May 17 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Director | Option Exercise | M | 3.87 | 9,000 | 34,830 | 0 | |
May 17 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Director | Option Exercise | M | 4.36 | 12,500 | 54,500 | 7,500 | |
May 17 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Director | Sell | S | 15.36 | 21,500 | 330,259 | 19,297 | 40.8 K to 19.3 K (-52.70 %) |
May 17 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Director | Buy | M | 3.87 | 9,000 | 34,830 | 40,797 | 31.8 K to 40.8 K (+28.30 %) |
May 17 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Director | Buy | M | 4.36 | 12,500 | 54,500 | 31,797 | 19.3 K to 31.8 K (+64.78 %) |
Apr 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Option Exercise | M | 3.87 | 16,000 | 61,920 | 9,000 | ||
Apr 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Option Exercise | M | 3.51 | 5,500 | 19,305 | 0 | ||
Apr 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Sell | S | 15.19 | 21,500 | 326,585 | 19,297 | 40.8 K to 19.3 K (-52.70 %) | |
Apr 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Buy | M | 3.87 | 16,000 | 61,920 | 40,797 | 24.8 K to 40.8 K (+64.52 %) | |
Apr 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Buy | M | 3.51 | 5,500 | 19,305 | 24,797 | 19.3 K to 24.8 K (+28.50 %) | |
Mar 21 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Option Exercise | M | 3.51 | 14,500 | 50,895 | 5,500 | ||
Mar 21 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Option Exercise | M | 3.37 | 7,000 | 23,590 | 0 | ||
Mar 21 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Sell | S | 16.76 | 21,500 | 360,340 | 19,297 | 40.8 K to 19.3 K (-52.70 %) | |
Mar 21 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Buy | M | 3.51 | 14,500 | 50,895 | 40,797 | 26.3 K to 40.8 K (+55.14 %) | |
Mar 21 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Buy | M | 3.37 | 7,000 | 23,590 | 26,297 | 19.3 K to 26.3 K (+36.28 %) | |
Mar 06 2018 | MTSI | MACOM Technology S ... | VAN LUNSEN GIL J | Director | Grant | A | 0.00 | 6,086 | 0 | 20,875 | 14.8 K to 20.9 K (+41.15 %) |
Feb 23 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Option Exercise | M | 2.46 | 13,500 | 33,210 | 0 | ||
Feb 23 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Option Exercise | M | 2.46 | 13,500 | 33,210 | 0 | ||
Feb 23 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Option Exercise | M | 3.37 | 8,000 | 26,960 | 7,000 | ||
Feb 23 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Option Exercise | M | 3.37 | 8,000 | 26,960 | 7,000 | ||
Feb 23 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Sell | S | 17.16 | 21,500 | 368,940 | 19,297 | 40.8 K to 19.3 K (-52.70 %) | |
Feb 23 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Sell | S | 17.16 | 21,500 | 368,940 | 19,297 | 40.8 K to 19.3 K (-52.70 %) | |
Feb 23 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Buy | M | 3.37 | 8,000 | 26,960 | 40,797 | 32.8 K to 40.8 K (+24.39 %) | |
Feb 23 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Buy | M | 3.37 | 8,000 | 26,960 | 40,797 | 32.8 K to 40.8 K (+24.39 %) | |
Feb 23 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Buy | M | 2.46 | 13,500 | 33,210 | 32,797 | 19.3 K to 32.8 K (+69.96 %) | |
Feb 23 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Buy | M | 2.46 | 13,500 | 33,210 | 32,797 | 19.3 K to 32.8 K (+69.96 %) | |
Jan 17 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Option Exercise | M | 1.74 | 15,000 | 26,100 | 0 | ||
Jan 17 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Option Exercise | M | 2.46 | 6,500 | 15,990 | 13,500 | ||
Jan 17 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Sell | S | 12.94 | 21,500 | 278,210 | 19,297 | 40.8 K to 19.3 K (-52.70 %) | |
Jan 17 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Buy | M | 2.46 | 6,500 | 15,990 | 40,797 | 34.3 K to 40.8 K (+18.95 %) | |
Jan 17 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Buy | M | 1.74 | 15,000 | 26,100 | 34,297 | 19.3 K to 34.3 K (+77.73 %) | |
Nov 13 2017 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Sell | D | 10.90 | 1,035 | 11,282 | 19,297 | 20.3 K to 19.3 K (-5.09 %) | |
Oct 27 2017 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Option Exercise | M | 0.00 | 5,000 | 0 | 0 | ||
Oct 27 2017 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | ||
Oct 27 2017 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Option Exercise | A | 10.47 | 25,000 | 261,750 | 25,000 | ||
Oct 27 2017 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Buy | M | 10.47 | 5,000 | 52,350 | 20,332 | 15.3 K to 20.3 K (+32.61 %) | |
Sep 29 2017 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Option Exercise | M | 10.58 | 45,000 | 476,100 | 0 | ||
Sep 29 2017 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Sell | S | 12.36 | 39,928 | 493,510 | 15,332 | 55.3 K to 15.3 K (-72.25 %) | |
Sep 29 2017 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Buy | M | 10.58 | 45,000 | 476,100 | 55,260 | 10.3 K to 55.3 K (+438.60 %) | |
May 25 2017 | MTSI | MACOM Technology S ... | VAN LUNSEN GIL J | Director | Sell | S | 60.01 | 2,000 | 120,020 | 14,789 | 16.8 K to 14.8 K (-11.91 %) |
Apr 13 2017 | MTSI | MACOM Technology S ... | VAN LUNSEN GIL J | Director | Sell | S | 50.85 | 962 | 48,918 | 16,789 | 17.8 K to 16.8 K (-5.42 %) |
Mar 16 2017 | MTSI | MACOM Technology S ... | VAN LUNSEN GIL J | Director | Sell | S | 46.05 | 1,000 | 46,050 | 17,751 | 18.8 K to 17.8 K (-5.33 %) |
Mar 07 2017 | MTSI | MACOM Technology S ... | VAN LUNSEN GIL J | Director | Grant | A | 0.00 | 2,835 | 0 | 18,751 | 15.9 K to 18.8 K (+17.81 %) |
Feb 16 2017 | MTSI | MACOM Technology S ... | VAN LUNSEN GIL J | Director | Sell | S | 45.47 | 1,000 | 45,470 | 15,916 | 16.9 K to 15.9 K (-5.91 %) |
Jan 19 2017 | MTSI | MACOM Technology S ... | VAN LUNSEN GIL J | Director | Sell | S | 46.83 | 1,000 | 46,830 | 16,916 | 17.9 K to 16.9 K (-5.58 %) |
Dec 15 2016 | MTSI | MACOM Technology S ... | VAN LUNSEN GIL J | Director | Sell | S | 49.13 | 1,000 | 49,130 | 17,916 | 18.9 K to 17.9 K (-5.29 %) |
Nov 17 2016 | MTSI | MACOM Technology S ... | VAN LUNSEN GIL J | Director | Sell | S | 40.69 | 1,000 | 40,690 | 18,916 | 19.9 K to 18.9 K (-5.02 %) |
Oct 31 2016 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Option Exercise | M | 0.00 | 5,000 | 0 | 0 | ||
Oct 31 2016 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Option Exercise | A | 5.95 | 25,000 | 148,750 | 25,000 | ||
Oct 31 2016 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | ||
Oct 31 2016 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Buy | M | 5.83 | 5,000 | 29,150 | 10,260 | 5.3 K to 10.3 K (+95.06 %) | |
Oct 13 2016 | MTSI | MACOM Technology S ... | VAN LUNSEN GIL J | Director | Sell | S | 42.17 | 1,000 | 42,170 | 19,916 | 20.9 K to 19.9 K (-4.78 %) |
Sep 15 2016 | MTSI | MACOM Technology S ... | VAN LUNSEN GIL J | Director | Sell | S | 41.06 | 1,000 | 41,060 | 20,916 | 21.9 K to 20.9 K (-4.56 %) |
Aug 24 2016 | MTSI | MACOM Technology S ... | VAN LUNSEN GIL J | Director | Sell | S | 40.00 | 1,000 | 40,000 | 21,916 | 22.9 K to 21.9 K (-4.36 %) |
Aug 01 2016 | MTSI | MACOM Technology S ... | VAN LUNSEN GIL J | Director | Sell | S | 40.00 | 2,000 | 80,000 | 22,916 | 24.9 K to 22.9 K (-8.03 %) |
Mar 08 2016 | MTSI | MACOM Technology S ... | VAN LUNSEN GIL J | Director | Grant | A | 0.00 | 3,113 | 0 | 24,916 | 21.8 K to 24.9 K (+14.28 %) |
Nov 02 2015 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Option Exercise | A | 5.13 | 25,000 | 128,250 | 25,000 | ||
Nov 02 2015 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | ||
May 19 2015 | MTSI | MACOM Technology S ... | VAN LUNSEN GIL J | Director | Grant | A | 0.00 | 1,577 | 0 | 21,803 | 20.2 K to 21.8 K (+7.80 %) |
Mar 24 2005 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Director | Buy | P | 7.47 | 860 | 6,424 | 3,260 | 2.4 K to 3.3 K (+35.83 %) |
Mar 24 2005 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Director | Buy | P | 7.47 | 455 | 3,399 | 2,400 | 1.9 K to 2.4 K (+23.39 %) |
Nov 03 2004 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Director | Option Exercise | A | 7.21 | 10,000 | 72,100 | 10,000 | |
Nov 12 2003 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Director | Buy | P | 5.00 | 1,365 | 6,825 | 1,945 | 580 to 1.9 K (+235.34 %) |
Nov 12 2003 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Director | Buy | P | 5.00 | 580 | 2,900 | 580 | 0 to 580 |
Nov 12 2003 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Director | Buy | P | 5.00 | 1,365 | 6,825 | 1,945 | 580 to 1.9 K (+235.34 %) |
Nov 12 2003 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Director | Buy | P | 5.00 | 580 | 2,900 | 580 | 0 to 580 |
Page: 1